SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-03-04 20:37
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol 		$100,000
Filed 2026-03-04 20:28
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol
Filed 2026-03-04 15:01
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol
Filed 2026-03-04 15:01
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol 		$100,000
Filed 2026-03-04 15:01
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-22 10:44
Tx date 2025-05-21 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		40,000
Filed 2026-01-22 10:38
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-11-04 17:55
Tx date 2025-11-03 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$245.00
+100 vol
$2.45 each 		25,900
Filed 2025-11-03 10:39
Tx date 2025-10-31 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,105
+2,900 vol
$2.45 each 		25,800
Filed 2025-10-30 12:21
Tx date 2025-10-29 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,220
+2,000 vol
$2.61 each 		22,900
Filed 2025-10-28 17:31
Tx date 2025-10-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,393
+1,300 vol
$2.61 each 		20,900
Filed 2025-10-27 10:49
Tx date 2025-10-24 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,305
+500 vol
$2.61 each 		19,600
Filed 2025-10-23 13:15
Tx date 2025-10-22 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,917
+3,800 vol
$2.61 each 		19,100
Filed 2025-10-23 13:15
Tx date 2025-10-21 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,874
+3,400 vol
$2.61 each 		15,300
Filed 2025-10-21 14:51
Tx date 2025-10-20 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$522.00
+200 vol
$2.61 each 		11,900
Filed 2025-10-21 14:51
Tx date 2025-10-20 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$512.00
+200 vol
$2.56 each 		11,700
Filed 2025-10-21 14:50
Tx date 2025-10-17 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$764.97
+300 vol
$2.55 each
Filed 2025-10-21 14:47
Tx date 2025-10-17 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$764.97
+300 vol
$2.55 each
Filed 2025-10-20 11:15
Tx date 2025-10-16 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$633.00
+300 vol
$2.11 each 		9,100
Filed 2025-10-20 11:15
Tx date 2025-10-16 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$420.00
+200 vol
$2.10 each 		8,800